Collaborative research partnerships give Bonfils the opportunity to save and enhance lives in a different way. Bonfils is proud to be part of scientific advancements in transfusion medicine by offering our services and expertise in clinical trials, hospital-initiated studies and specialty contract research services to pharmaceutical, biotechnology, biomaterial and medical device clients. Many of these research projects are focused on continually improving blood transfusions for patients but Bonfils has also participated in studies that focus on the donor. Past projects have included studying ways to improve the donor experience for automated donation, assisting in the manufacturing of pharmaceutical products including treatment for patients with prostate cancer, examining the effects of treating severely ill patients with granulocytes (a type of white blood cell), and more. 

Bonfils’ headquarters is also home to Dr. Christopher Silliman’s research laboratory which partners with the University of Colorado School of Medicine’s Hematology, Oncology and BMT Research Program and Children’s Hospital Colorado Center for Cancer and Blood Disorders. The primary interest of this laboratory is to examine the effects of blood transfusion on the immune system and to identify ways to mitigate transfusion-related complications that may arise.